Publication:
Proliferative vitreoretinopathy: an update on the current and emerging treatment options.

Simple item page
cris.virtual.author-orcid0000-0003-0715-6369
cris.virtual.author-orcid0000-0003-3447-2359
cris.virtualsource.author-orcidcaef0a07-effd-4fab-a725-aa9f0ee43891
cris.virtualsource.author-orcidc085bd92-a4c3-4c41-89e4-db5ff7d0a67f
cris.virtualsource.author-orcid6ed63009-f93f-4944-9653-2d043162be6e
cris.virtualsource.author-orcidfed58d8f-d8d1-4474-a2e1-17b917714f0b
cris.virtualsource.author-orcide9ec4e2f-198b-4275-9b8c-c22eb13c6bb3
datacite.rightsopen.access
dc.contributor.authorFerro Desideri, Lorenzo
dc.contributor.authorArtemiev, Dmitri
dc.contributor.authorZandi, Souska Sophie
dc.contributor.authorZinkernagel, Martin Sebastian
dc.contributor.authorAnguita Henríquez, Rodrigo Andrés
dc.date.accessioned2024-10-25T18:19:56Z
dc.date.available2024-10-25T18:19:56Z
dc.date.issued2024-03
dc.description.abstractProliferative vitreoretinopathy (PVR) remains the main cause of failure in retinal detachment (RD) surgery and a demanding challenge for vitreoretinal surgeons. Despite the large improvements in surgical techniques and a better understanding of PVR pathogenesis in the last years, satisfactory anatomical and visual outcomes have not been provided yet. For this reason, several different adjunctive pharmacological agents have been investigated in combination with surgery. In this review, we analyze the current and emerging adjunctive treatment options for the management of PVR and we discuss their possible clinical application and beneficial role in this subgroup of patients.
dc.description.numberOfPages9
dc.description.sponsorshipUniversitätsklinik für Augenheilkunde
dc.identifier.doi10.48350/187234
dc.identifier.pmid37843566
dc.identifier.publisherDOI10.1007/s00417-023-06264-1
dc.identifier.urihttps://boris-portal.unibe.ch/handle/20.500.12422/170702
dc.language.isoen
dc.publisherSpringer
dc.relation.ispartofGraefe's archive for clinical and experimental ophthalmology
dc.relation.issn1435-702X
dc.relation.organizationDCD5A442BB12E17DE0405C82790C4DE2
dc.relation.organizationDCD5A442C4CAE17DE0405C82790C4DE2
dc.relation.organizationDCD5A442BD18E17DE0405C82790C4DE2
dc.subjectMethotrexate PVR Proliferative vitreoretinopathy Steroids Vitrectomy
dc.subject.ddc600 - Technology::610 - Medicine & health
dc.titleProliferative vitreoretinopathy: an update on the current and emerging treatment options.
dc.typearticle
dspace.entity.typePublication
dspace.file.typetext
oaire.citation.endPage687
oaire.citation.issue3
oaire.citation.startPage679
oaire.citation.volume262
oairecerif.author.affiliationUniversitätsklinik für Augenheilkunde
oairecerif.author.affiliationUniversitätsklinik für Augenheilkunde
oairecerif.author.affiliationUniversitätsklinik für Augenheilkunde
oairecerif.author.affiliationUniversitätsklinik für Augenheilkunde
oairecerif.author.affiliationUniversitätsklinik für Augenheilkunde
oairecerif.author.affiliation2Department for BioMedical Research (DBMR)
oairecerif.author.affiliation2Universitätsklinik für Augenheilkunde
oairecerif.author.affiliation3Department for BioMedical Research, Forschungsgruppe Augenheilkunde
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.date.licenseChanged2023-10-18 14:19:02
unibe.description.ispublishedpub
unibe.eprints.legacyId187234
unibe.refereedtrue
unibe.subtype.articlereview

Files

Original bundle
Now showing 1 - 1 of 1
Name:
s00417-023-06264-1.pdf
Size:
658.93 KB
Format:
Adobe Portable Document Format
File Type:
text
License:
https://creativecommons.org/licenses/by/4.0
Content:
published
Download

Collections

Publications